Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23319132 | 1.00 | CA1 (0.30) | CA1CA9 | |
| SCHEMBL22144691 | 1.00 | CA1 (0.30) | CA1CA9 | |
| SCHEMBL949605 | 0.87 | — | — | |
| SCHEMBL34400 | 0.84 | — | — | |
| SCHEMBL3553194 | 0.84 | — | — | |
| SCHEMBL2243896 | 0.84 | — | — | |
| SCHEMBL21755500 | 0.82 | CYP1A2 (0.32) | — | |
| SCHEMBL4438071 | 0.79 | LMNA (0.33) | — | |
| SCHEMBL14028838 | 0.79 | LMNA (0.33) | — | |
| SCHEMBL17583103 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6750291-B2 | POLYURETHANE AND 1*50% BY WEIGHT ADDITION POLYMERIZATION POLYMER HAVING FUNCTIONAL GROUP OF CARBOXYLIC ACID DERIVATIVE; TRANSDERMAL DRUG DELIVERY | PACIFIC CORPORATION (KR) | 2004-06-15 | — | — | US | claimed |
| US-20030199644-A1 | Film-forming agent for drug delivery and preparation for percutaneous administration containing the same | PACIFIC CORPORATION (KR) | 2003-10-23 | — | — | US | claimed |
| CN-117866183-A | Absorbable segmented copolymer, preparation method, application and absorbable binding belt | 成都瑞诺美捷医疗器械有限公司 | 2024-04-12 | — | — | CN | disclosed |
| US-20240066039-A1 | LIQUID POLYMER DELIVERY SYSTEM FOR EXTENDED ADMINISTRATION OF DRUGS | TOLMAR INTERNATIONAL LIMITED (IE) | 2024-02-29 | — | — | US | disclosed |
| US-10035877-B1 | Matrix-bondable lactide monomors for polylactide synthesis | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2018-07-31 | — | — | US | disclosed |
| EP-3339348-A1 | POLYLACTIDE COMPOSITIONS AND USES THEREOF | Universite De Geneve (CH) | 2018-06-27 | — | — | EP | disclosed |
| EP-2285350-B1 | METHODS FOR THE PREPARATION OF TARGETING AGENT FUNCTIONALIZED DIBLOCK COPOLYMERS FOR USE IN FABRICATION OF THERAPEUTIC NANOPARTICLES | PFIZER (US) | 2017-11-15 | — | — | EP | disclosed |
| US-8734846-B2 | Methods for the preparation of targeting agent functionalized diblock copolymers for use in fabrication of therapeutic targeted nanoparticles | BIND BIOSCIENCES, INC. (US) | 2014-05-27 | — | — | US | disclosed |
| US-20130115192-A1 | Methods for the Preparation of Targeting Agent Functionalized Diblock Copolymers for Use in Fabrication of Therapeutic Targeted Nanoparticles | BIND BIOSCIENCES, INC (US) | 2013-05-09 | — | — | US | disclosed |
| US-20130030212-A1 | COMPOUND HAVING ALICYCLIC STRUCTURE, (METH)ACRYLIC ACID ESTER, AND PROCESS FOR PRODUCTION OF THE (METH)ACRYLIC ACID ESTER | IDEMITSU KOSAN CO., LTD. (JP) | 2013-01-31 | — | — | US | disclosed |
| US-20130023693-A1 | COMPOUND HAVING ALICYCLIC STRUCTURE, (METH)ACRYLIC ACID ESTER, AND PROCESS FOR PRODUCTION OF THE (METH)ACRYLIC ACID ESTER | IDEMITSU KOSAN CO., LTD. (JP) | 2013-01-24 | — | — | US | disclosed |
| US-7557176-B2 | Polyhydroxyalkanoic acid having vinyl, ester, carboxyl or sulfonic acid group and producing method therefor | CANON KABUSHIKI KAISHA (JP) | 2009-07-07 | — | — | US | disclosed |
| US-20080311478-A1 | Lithium Secondary Battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2008-12-18 | — | — | US | disclosed |
| WO-2008104757-A1 | POLYLACTIC ACID STEREOCOMPLEX | TATE & LYLE PUBLIC LIMITED COMPANY (GB) | 2008-09-04 | — | — | WO | disclosed |
| US-20080207840-A1 | Heat resistant blends; injection molding; controlling temperature, pressure; high molecular weight | TATE & LYLE PUBLIC LIMITED COMPANY (GB) | 2008-08-28 | — | — | US | disclosed |
| EP-1892789-A1 | LITHIUM SECONDARY BATTERY | Mitsubishi Chemical Corporation (JP) | 2008-02-27 | — | — | EP | disclosed |
| US-20050009687-A1 | Titanium alkoxide catalysts for polymerization of cyclic esters and methods of polymerization | NATIONAL SCIENCE FOUNDATION | 2005-01-13 | — | — | US | disclosed |
| US-6469133-B2 | SUCH AS CRYSTALLINE POLYLACTIDE AND POLYMANDELIDE, FROM SUBSTITUTED 1,4-DIOXAN-2,5-DIONES BY MIXING AN ANHYDROUS METAL ORGANIC LIGAND WITH THE DIOXANEDIONE AND HEATING; HIGH MELTING BIODEGRADABLE POLYMERS | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY | 2002-10-22 | — | — | US | disclosed |
| US-20010044514-A1 | Process for the preparation of polymers of dimeric cyclic esters | BOARD OF TRUSTEES OPERATING MICHIGAN STATE UNIVERSITY | 2001-11-22 | — | — | US | disclosed |
| US-5247013-A | Biocompatible polyester and production thereof | MITSUI TOATSU CHEMICALS, INC. (JP) | 1993-09-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130030212-A1 | COMPOUND HAVING ALICYCLIC STRUCTURE, (METH)ACRYLIC ACID ESTER, AND PROCESS FOR PRODUCTION OF THE (METH)ACRYLIC ACID ESTER | ALAD, MMAB, MAT1A | CA1 3571/4885CA9 2967/4885 |
| US-20130023693-A1 | COMPOUND HAVING ALICYCLIC STRUCTURE, (METH)ACRYLIC ACID ESTER, AND PROCESS FOR PRODUCTION OF THE (METH)ACRYLIC ACID ESTER | ALAD, MMAB, MAT1A | CA1 3571/4885CA9 2967/4885 |
| US-20240066039-A1 | LIQUID POLYMER DELIVERY SYSTEM FOR EXTENDED ADMINISTRATION OF DRUGS | VEGFA, HACD3, HACD2 | CA1 1099/4885CA9 937/4885 |
| US-20130115192-A1 | Methods for the Preparation of Targeting Agent Functionalized Diblock Copolymers for Use in Fabrication of Therapeutic Targeted Nanoparticles | GNE, PAM, EPHA2 | CA1 2391/4885CA9 1761/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.